United States · Series D startup

Who invested in Cellares

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$257Mraised across 1 round since 2026, from 1 source

Latest round
Series D, $257MJan 2026
Investors
2
See who backed them

The rounds

  1. Jan 2026
    Series D$257M

    Source recorded

Founders and team

From the SEC filings it signed: 2 founders.

Fabian GerlinghausCo-Founder & CEO, CellaresNamed on its 2021 Form D
Omar KurdiCo-Founder & President, CellaresNamed on its 2021 Form D

On the board, as filediJustin Butler

Everyone who backed them

8VCVC firm1round
BlackRockAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Cellares as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

EcoR1 CapitalPrivate equityPer its own site
Decheng CapitalVC firmPer its own site
Intuitive VenturesAcceleratorPer its own site
VONROSENFamily officePer its own site

Quick answers about Cellares

Who invested in Cellares?

Cellares's investors include 8VC and BlackRock.

How much has Cellares raised?

Cellares has raised $257M across 1 round since 2026.

When did Cellares last raise?

Cellares's most recent round was a Series D of $257M in Jan 2026.

What was Cellares's biggest round?

Its most recent round, $257M in Jan 2026, is also its largest on record.

Who backed Cellares first?

Cellares's first round on record, in Jan 2026, was backed by 8VC and BlackRock.

What stage is Cellares at?

Cellares's latest named round is a Series D, in Jan 2026.

Where is Cellares based?

Cellares is based in the United States.

Companies like Cellares

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.